| | |
PATTERSON COMPANIES | 1031 Mendota Heights Road | Saint Paul, MN 55120 | | NEWS RELEASE |
Patterson Dental
Reported net sales in our Dental segment for the fourth quarter of fiscal 2022 were $636.4 million. Internal sales increased 3.4 percent compared to the fiscal 2021 fourth quarter. Internal sales of consumables declined 0.8 percent year-over-year primarily due to the continued moderation of infection control products compared to the pandemic-related performance in the year-ago period. Excluding infection control products, internal sales of consumables increased 2.9 percent over the prior year period. Internal sales of equipment increased 14.3 percent year-over-year driven by strong performance in digital technology and CAD/CAM products and positive growth in the core equipment category. Internal sales of value-added services decreased 3.2 percent year-over-year compared to the prior year period.
Patterson Animal Health
Reported net sales in our Animal Health segment for the fourth quarter of fiscal 2022 were $1.0 billion. Internal sales growth of 7.6 percent was driven by mid-single digit growth in companion animal and double-digit growth in production animal. Within the Animal Health segment, internal sales of consumables grew 7.4 percent, equipment and software increased 22.0 percent and value-added services decreased 7.2 percent over the prior year period.
Balance Sheet and Capital Allocation
During fiscal 2022, Patterson Companies used $981.0 million of cash from operating activities and collected deferred purchase price receivables of $1,213.5 million, generating $232.5 million in cash, compared to generating $103.4 million during fiscal 2021. Free cash flow1 (see definition below and attached free cash flow table) during fiscal 2022 improved by $116.5 million compared to the fiscal 2021 period due to a decreased level of working capital during fiscal 2022.
In the fourth quarter of fiscal 2022, Patterson Companies declared a quarterly cash dividend of $0.26 per share and returned $25.4 million in cash dividends to shareholders. Also, under an existing repurchase authorization, the company repurchased approximately 1.0 million shares. At of the end of fiscal 2022, Patterson had approximately $465 million of share repurchase authority remaining on its current share repurchase authorization. During fiscal 2022, Patterson Companies returned $136.1 million to shareholders in the form of cash dividends and share repurchases.
Year-to-Date Results
Consolidated reported net sales for fiscal 2022 totaled $6.5 billion, a 9.9 percent year-over-year increase. Sales in fiscal 2022 reflected an extra week of sales results in the fiscal first quarter versus the prior year. Internal sales, which are adjusted for the effects of currency translation, changes in product selling relationships, contributions from recent acquisitions and the extra week of selling results in the first quarter of fiscal 2022, increased 9.1 percent compared to fiscal 2021. During fiscal 2022, Dental segment internal sales increased 5.8 percent, including 5.8 percent growth in consumables and 7.6 percent growth in equipment and software. In fiscal 2022, Animal Health segment internal sales increased 12.1 percent, including 11.6 percent growth in consumables and 29.9 percent growth in equipment and software.
Reported net income attributable to Patterson Companies, Inc. in fiscal 2022 was $203.2 million, or $2.06 per diluted share, compared to a $156.0 million, or $1.61 per diluted share in fiscal 2021. Adjusted net income1 attributable to Patterson Companies, Inc. in fiscal 2022, which excludes gains on investments, inventory donation charges, deal amortization, legal reserves and integration and business restructuring expenses totaled $223.7 million, or $2.27 per diluted share, compared to $185.0 million, or $1.91 per diluted share, in the prior fiscal year. Patterson estimates the extra selling week in fiscal 2022 contributed approximately $0.04 to adjusted earnings per diluted share compared to the prior year.
Fiscal 2023 Guidance
![LOGO](https://capedge.com/proxy/8-K/0001193125-22-184422/g286787g0629014609610.jpg)